SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14C - Additional information statement materials, definitive:
SEC Accession No. 0001193125-19-123859
Filing Date
2019-04-29
Accepted
2019-04-29 08:43:55
Documents
6
Effectiveness Date
2019-04-29

Document Format Files

Seq Description Document Type Size
1 DEFA14C d731282ddefa14c.htm DEFA14C 33503
2 GRAPHIC g731282snap0001.jpg GRAPHIC 2478
3 GRAPHIC g731282snap0002.jpg GRAPHIC 1291
4 GRAPHIC g731282snap0003.jpg GRAPHIC 1265
5 GRAPHIC g731282snap0004.jpg GRAPHIC 1282
6 GRAPHIC g731282snap0005.jpg GRAPHIC 1272
  Complete submission text file 0001193125-19-123859.txt   45728
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14C | Act: 34 | File No.: 001-38137 | Film No.: 19773891
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1